Healthcare Stocks Mixed Ahead of Closing Bell; GW Pharma Adds 7% After MS Drug Approved in Switzerland


Top Healthcare Stocks

JNJ -0.05%

PFE 0.00%

ABT +0.74%

MRK +0.36%

AMGN -0.16%

Healthcare stocks are narrowly mixed in late trade with the NYSE Healthcare Sector Index slipping 0.1% while shares of healthcare companies in the S&P 500 are ahead 0.1% as a group.

In company news, GW Pharma ( GWPH ) is up 7.1% at $37.50 a share in late trade after saying it has received regulatory approval for its Sativex Multiple Sclerosis medication in Switzerland.

Full marketing authorization has been granted by the Swissmedic authorities in the treatment of moderate to severe spasticity in MS patients who have not responded adequately to other anti-spasticity medications.

GWPH said timing for a commercial launch of the drug depends on completion of pricing and reimbursement procedures, with the company's European partner, Almirall SA, leading those efforts.

In other sector news,

(+) DRTX, FDA accepts Dalvance new drug application, placing the prospective treatment for patients with acute bacterial skin and skin structure infections on the fast track for priority review with a May 26, 2014, action date.

(-) ACST, Prices public offering of 16 mln units at $1.25 apiece and consisting of one Class A share and a five-year warrant to buy an additional share of common stock.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

Referenced Stocks: GWPH

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos



Most Active by Volume

  • $10.50 ▲ 3.04%
  • $29.22 ▲ 4.62%
  • $16.36 ▼ 0.49%
  • $113.29 ▲ 0.33%
  • $2.39 ▲ 4.82%
  • $5.78 ▲ 0.87%
  • $105.62 ▼ 0.02%
  • $28.42 ▲ 2.53%
As of 8/28/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by